R-phenylisopropyladenosine

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameR-phenylisopropyladenosine
Drug Alias NameR-PIA
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionAdenosine A1 receptor agonists
TargetsAdenosine A1 receptor
Therapy Area/IndicationsHearing Loss
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPending (Clinical)
Highest Status in ChinaN/A
Originator CompaniesCentral State University Of New York Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesCentral State University Of New York Inc
Active IndicationsN/A
Inactive IndicationsHearing Loss

Other Information

ATC CodeN/A
Related LinksN/A